← All organizations

Cadent Therapeutics

Cadent Therapeutics

For profitWebsite ↗

Also known as: Cadent Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 31, 2020

Acquired by Novartis on Dec 17, 2020

Timeline

2010s

Jun 1, 2010
Cadent Therapeutics— Founded

2020s

Dec 17, 2020
Novartis— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

cad-1883

Phase 1 (1 own, 0 via acquisition)

Plazinemdor

Indications

Studied for

Recent trials (3)

NCT04301284Lead sponsorPhase 2Aug 31, 2020
NCT04306146Lead sponsorPhase 1Feb 28, 2020
NCT03688685Lead sponsorPhase 2Nov 30, 2018

Details

Founded: Cambridge, MA, US Jun 1, 2010
Last known activity: Aug 31, 2020